Hints and tips:
Related Special Reports
...The three-way link up is set to be unveiled on Monday at an event in Helsingør, north of Copenhagen, to mark the Novo Nordisk Foundation’s 100th anniversary....
...Novo Nordisk is acquiring plants that specialise in “fill-finish” operations, the final stage of manufacturing drugs, in Indiana, Brussels and Anagni, Italy....
...North America accounted for half the company’s sales in 2022, twice as much as Europe, the Middle East and Africa....
...The top performer in the past 12 months is Novo Nordisk, which has been boosted by investor enthusiasm over its weight loss and diabetes drugs, and is up 69 per cent....
...Danish drugmaker Novo Nordisk developed semaglutide, branded as Ozempic for people with diabetes and Wegovy for weight loss....
...The “Granolas”, a recently coined acronym for Europe’s 11 best performing stocks, include the global obesity drug market leader, Novo Nordisk, chip technology company ASML and the food giant Nestlé....
...Its $610bn market capitalisation makes it the ninth biggest company on the S&P 500. It has America’s obesity epidemic to thank....
...The speed of adoption will also depend on Novo Nordisk scaling up supply....
...Weight loss Denmark is beginning to feel the effects of Novo Nordisk’s exceptional growth and they’re not all positive, Bloomberg reports....
...Nordisk and SAP — account for more than all the gains in the Stoxx 600 this year....
...Demand in the US and Europe is surging for treatments such as Wegovy, the weight-loss drug from Danish company Novo Nordisk, which was shown in a trial to reduce the risk of death by 18 per cent....
...The warmer than usual start to winter has also driven ice cover to its lowest level for 50 years in North America’s Great Lakes....
...The US has its “Magnificent Seven” tech stocks, Japan has its “Seven Samurai” and Europe has the “Granolas”: GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP and Sanofi....
...As Andrew O’Neill, managing director of S&P Global’s Digital Assets Research Lab noted yesterday: Some operations will become non-profitable and will shut down as result, particularly those with higher...
...What a difference. Jeffrey S Merrifield and his team at Pillsbury topped the energy transition category in the FT’s 2023 North America Innovative Lawyers Awards...
...Graham Capital Management is planning to expand to New York after decades as a Connecticut-based hedge fund, in a vote on the future of America’s financial capital following an exodus of investment firms...
...Need to know: Business Danish drugmaker Novo Nordisk’s breakthrough weight-loss and diabetes drugs have helped it become Europe’s largest drugmaker....
...Semaglutide can carry enormous benefits to its users, as Novo Nordisk has said....
...The best S&P 500 companies have become cash-returning machines. Furthermore, there is currently no evidence of a bubble in price-to-earnings ratios....
...The headlines Novo Nordisk has overtaken French luxury goods group LVMH as Europe’s most valuable company. The Danish drug maker is now worth $428bn....
...where it has substantial manufacturing operations....
...The S&P PMI survey started this year with three back-to-back expansionary readings after spending much of 2023 in contraction territory....
...It is somewhat ironic that Denmark’s economic growth in the first half of the year was driven almost entirely by the stellar performance of Novo Nordisk, a Danish pharmaceutical group....
...The success of weight loss drugs from Novo Nordisk and Eli Lilly has prompted other invidious comparisons. Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn....
...But “achieving security and co-operation in a fractured world” and artificial intelligence dominated the agenda. Jobs and growth and the compulsory climate stuff were sideshows....
International Edition